Related Experiment Video
Updated: May 22, 2026

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
[The designs of exploratory biomarker study]
Masahiko Gosho1, Kengo Nagashima, Yasunori Sato
1Graduate School of Engineering, Tokyo University of Science.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 25, 2012
Summary
Biomarker validation in clinical research requires careful consideration of scientific rationale, study design, and cost. This review highlights key aspects for designing clinical studies incorporating biomarkers for drug discovery and development.
Area of Science:
- Biomarker discovery and validation
- Molecular biology applications
- Clinical research methodology
Context:
- Biomarkers are crucial in modern drug discovery and development.
- Clinical research designs must address scientific rationale, study design, marker assessment, cost, and feasibility.
- Distinguishing between prognostic and predictive markers is essential.
Purpose:
- To define biomarkers and differentiate prognostic from predictive types.
- To outline study design considerations for exploratory biomarker screening and evaluation.
- To review the design of confirmatory clinical trials for novel treatments and companion diagnostics.
Summary:
- This review emphasizes critical considerations for clinical research designs involving biomarkers.
- It covers the definition and types of biomarkers, exploratory study designs for biomarker evaluation, and confirmatory trial designs for treatments and companion diagnostics.
- Key aspects include scientific rationale, study design, marker assessment, cost, and feasibility.
Impact:
- Provides a framework for optimizing biomarker validation in clinical research.
- Aids in the efficient development of targeted therapies and companion diagnostics.
- Enhances the integration of biomarkers into drug discovery and development pipelines.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Study Design in Statistics
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
